Accolade Net Worth
Accolade Net Worth Breakdown | ACCD |
Accolade Net Worth Analysis
Accolade's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Accolade's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Accolade's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Accolade's net worth analysis. One common approach is to calculate Accolade's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Accolade's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Accolade's net worth. This approach calculates the present value of Accolade's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Accolade's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Accolade's net worth. This involves comparing Accolade's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Accolade's net worth relative to its peers.
Enterprise Value |
|
To determine if Accolade is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Accolade's net worth research are outlined below:
Accolade generated a negative expected return over the last 90 days | |
Accolade has high likelihood to experience some financial distress in the next 2 years | |
The company reported the previous year's revenue of 414.29 M. Net Loss for the year was (99.81 M) with profit before overhead, payroll, taxes, and interest of 165.26 M. | |
Accolade currently holds about 330.63 M in cash with (16.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Accolade has a poor financial position based on the latest SEC disclosures | |
Over 84.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from investing.com: Acclade CEO Rajeev Singh sells 1,271 in stock |
Accolade Quarterly Good Will |
|
Accolade uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Accolade. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Accolade's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
25th of April 2024 Upcoming Quarterly Report | View | |
4th of July 2024 Next Financial Report | View | |
29th of February 2024 Next Fiscal Quarter End | View | |
25th of April 2024 Next Fiscal Year End | View | |
30th of November 2023 Last Quarter Report | View | |
28th of February 2023 Last Financial Announcement | View |
Know Accolade's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Accolade is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Accolade backward and forwards among themselves. Accolade's institutional investor refers to the entity that pools money to purchase Accolade's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Geode Capital Management, Llc | 2024-09-30 | 1.8 M | Clearline Capital Lp | 2024-09-30 | 1.5 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.5 M | Prosight Management, Lp | 2024-06-30 | 1.5 M | D. E. Shaw & Co Lp | 2024-09-30 | 1.3 M | Fairman Group Llc | 2024-09-30 | 1.1 M | Jane Street Group Llc | 2024-06-30 | 1 M | Whetstone Capital Advisors, Llc | 2024-09-30 | 997.9 K | Goldman Sachs Group Inc | 2024-06-30 | 776.8 K | Blackrock Inc | 2024-06-30 | 6.2 M | Ark Investment Management Llc | 2024-09-30 | 5.4 M |
Follow Accolade's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 297.99 M.Market Cap |
|
Project Accolade's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.29) | (0.30) | |
Return On Capital Employed | (0.17) | (0.18) | |
Return On Assets | (0.13) | (0.13) | |
Return On Equity | (0.22) | (0.21) |
When accessing Accolade's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Accolade's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Accolade's profitability and make more informed investment decisions.
Please note, the presentation of Accolade's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Accolade's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Accolade's management manipulating its earnings.
Evaluate Accolade's management efficiency
Accolade has return on total asset (ROA) of (0.0727) % which means that it has lost $0.0727 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1861) %, meaning that it created substantial loss on money invested by shareholders. Accolade's management efficiency ratios could be used to measure how well Accolade manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2024, Return On Tangible Assets is expected to decline to -0.3. In addition to that, Return On Capital Employed is expected to decline to -0.18. At present, Accolade's Debt To Assets are projected to slightly decrease based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.89, whereas Net Tangible Assets are projected to grow to (249.7 M).Last Reported | Projected for Next Year | ||
Book Value Per Share | 5.95 | 3.07 | |
Tangible Book Value Per Share | 0.02 | 0.02 | |
Enterprise Value Over EBITDA | (11.57) | (12.15) | |
Price Book Value Ratio | 1.72 | 1.81 | |
Enterprise Value Multiple | (11.57) | (12.15) | |
Price Fair Value | 1.72 | 1.81 | |
Enterprise Value | 823.7 M | 422.7 M |
Accolade showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Enterprise Value Revenue 0.6858 | Revenue 441 M | Quarterly Revenue Growth 0.098 | Revenue Per Share 5.706 | Return On Equity (0.19) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Accolade insiders, such as employees or executives, is commonly permitted as long as it does not rely on Accolade's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Accolade insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Accolade Corporate Filings
F4 | 20th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 8th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 7th of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Accolade Earnings per Share Projection vs Actual
Accolade Corporate Management
Richard JD | General VP | Profile | |
Robert Cavanaugh | President | Profile | |
Michael Hilton | Chief Officer | Profile | |
James MD | Senior Officer | Profile | |
Kristin Herrera | Executive Business | Profile | |
Colin McHugh | Chief Officer | Profile | |
Jennifer Hanson | Executive Officer | Profile |
Already Invested in Accolade?
The danger of trading Accolade is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Accolade is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Accolade. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Accolade is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Accolade is a strong investment it is important to analyze Accolade's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Accolade's future performance. For an informed investment choice regarding Accolade Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accolade. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.02) | Revenue Per Share 5.706 | Quarterly Revenue Growth 0.098 | Return On Assets (0.07) | Return On Equity (0.19) |
The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accolade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accolade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.